Table of Contents
List of Tables 4
List of Figures 5
Report Guidance 6
GlobalData Clinical Trials Report Coverage 7
Clinical Trials by Region 8
Clinical Trials and Average Enrollment by Country 9
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 12
Top Five Countries Contributing to Clinical Trials in Europe 13
Top Countries Contributing to Clinical Trials in North America 14
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 15
Top Five Countries Contributing to Clinical Trials in Central and South America 16
Clinical Trials by G7 Countries: Proportion of Sicca Syndrome (Sjogren) to Immunology Clinical Trials 17
Clinical Trials by Phase in G7 Countries 18
Clinical Trials in G7 Countries by Trial Status 19
Clinical Trials by E7 Countries: Proportion of Sicca Syndrome (Sjogren) to Immunology Clinical Trials 20
Clinical Trials by Phase in E7 Countries 21
Clinical Trials in E7 Countries by Trial Status 22
Clinical Trials by Phase 23
In Progress Trials by Phase 24
Clinical Trials by Trial Status 25
Clinical Trials by End Point Status 26
Subjects Recruited Over a Period of Time 27
Clinical Trials by Sponsor Type 28
Prominent Sponsors 29
Top Companies Participating in Sicca Syndrome (Sjogren) Therapeutics Clinical Trials 31
Prominent Drugs 32
Latest Clinical Trials News on Sicca Syndrome (Sjogren) 33
Nov 12, 2019: Alpine Immune Sciences presents new ALPN-101 preclinical data at the 2019 American College of Rheumatology (ACR) Annual Meeting 33
Nov 11, 2019: Encouraging Phase 2 data on cenerimod – Idorsia’s S1P1 receptor modulator currently investigated for SLE – presented at ACR 2019 33
Oct 02, 2019: Alpine Immune Sciences announces upcoming scientific presentation of ALPN-101 at ACR/ARHP 2019 Annual Meeting 34
Oct 02, 2019: Data on cenerimod – Idorsia’s S1P1 receptor modulator – will be presented at the ACR / ARP Annual Meeting 2019 34
Clinical Trial Profile Snapshots 36
Appendix 172
Abbreviations 172
Definitions 172
Research Methodology 173
Secondary Research 173
About GlobalData 174
Contact Us 174
Source 175
Sicca Syndrome (Sjogren) Therapeutics, Global, Clinical Trials by Region, 2019* 8
Sicca Syndrome (Sjogren) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2019* 10
Sicca Syndrome (Sjogren) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2019* 11
Sicca Syndrome (Sjogren) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2019* 12
Sicca Syndrome (Sjogren) Therapeutics Clinical Trials, Europe, Top Five Countries, 2019* 13
Sicca Syndrome (Sjogren) Therapeutics Clinical Trials, North America, Top Countries, 2019* 14
Sicca Syndrome (Sjogren) Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2019* 15
Sicca Syndrome (Sjogren) Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2019* 16
Proportion of Sicca Syndrome (Sjogren) to Immunology Clinical Trials, G7 Countries (%), 2019* 17
Sicca Syndrome (Sjogren) Therapeutics, G7 Countries, Clinical Trials by Phase, 2019* 18
Sicca Syndrome (Sjogren) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2019* 19
Proportion of Sicca Syndrome (Sjogren) to Immunology Clinical Trials, E7 Countries (%), 2019* 20
Sicca Syndrome (Sjogren) Therapeutics, E7 Countries, Clinical Trials by Phase, 2019* 21
Sicca Syndrome (Sjogren) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2019* 22
Sicca Syndrome (Sjogren) Therapeutics, Global, Clinical Trials by Phase, 2019* 23
Sicca Syndrome (Sjogren) Therapeutics, Global, Clinical Trials In Progress by Phase 2019* 24
Sicca Syndrome (Sjogren) Therapeutics, Global, Clinical Trials by Trial Status, 2019* 25
Sicca Syndrome (Sjogren) Therapeutics Clinical Trials, Global, by End Point Status, 2019* 26
Sicca Syndrome (Sjogren) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2014-2018 27
Sicca Syndrome (Sjogren) Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2019* 28
Sicca Syndrome (Sjogren) Therapeutics Clinical Trials, Global, Key Sponsors, 2019* 30
Sicca Syndrome (Sjogren) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2019* 31
Sicca Syndrome (Sjogren) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2019* 32
List of Figures
Sicca Syndrome (Sjogren) Therapeutics, Global, Clinical Trials by Region (%), 2019* 8
Sicca Syndrome (Sjogren) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2019* 9
Sicca Syndrome (Sjogren) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2019* 11
Sicca Syndrome (Sjogren) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2019* 12
Sicca Syndrome (Sjogren) Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2019* 13
Sicca Syndrome (Sjogren) Therapeutics Clinical Trials, North America, Top Countries (%), 2019* 14
Sicca Syndrome (Sjogren) Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2019* 15
Sicca Syndrome (Sjogren) Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2019* 16
Proportion of Sicca Syndrome (Sjogren) to Immunology Clinical Trials, G7 Countries (%), 2019* 17
Sicca Syndrome (Sjogren) Therapeutics, G7 Countries, Clinical Trials by Phase, 2019* 18
Sicca Syndrome (Sjogren) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2019* 19
Proportion of Sicca Syndrome (Sjogren) to Immunology Clinical Trials, E7 Countries (%), 2019* 20
Sicca Syndrome (Sjogren) Therapeutics, E7 Countries, Clinical Trials by Phase, 2019* 21
Sicca Syndrome (Sjogren) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2019* 22
Sicca Syndrome (Sjogren) Therapeutics, Global, Clinical Trials by Phase (%), 2019* 23
Sicca Syndrome (Sjogren) Therapeutics, Global, Clinical Trials In Progress by Phase, 2019* 24
Sicca Syndrome (Sjogren) Therapeutics, Global, Clinical Trials by Trial Status, 2019* 25
Sicca Syndrome (Sjogren) Therapeutics Clinical Trials, Global, by End Point Status, 2019* 26
Sicca Syndrome (Sjogren) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2014-2018 27
Sicca Syndrome (Sjogren) Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2019* 28
Sicca Syndrome (Sjogren) Therapeutics Clinical Trials, Global, Key Sponsors, 2019* 29
Sicca Syndrome (Sjogren) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2019* 31
Sicca Syndrome (Sjogren) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2019* 32
GlobalData Methodology 173
【免責事項】
https://www.marketreport.jp/reports-disclaimer